Moving Science Forward, By Transforming More Lives

QuadroPharma is a global pharmaceutical marketing and sales company with a history of internal product development, acquisitions and exports.

Through a combination of innovation, collaboration and quality, QuadroPharma strives to address specific unmet medical needs.

Projected Compound Annual Growth Rate (CAGR) of Global Pharmaceutical Spending from 2023 to 2027: Analysis by Market and Product Types

Projected Compound Annual Growth Rate (CAGR) of Global Pharmaceutical Spending from 2023 to 2027: Analysis by Market and Product Types

June 20, 2024

Global pharmaceutical sales from 2020 to 2023, by region

Global pharmaceutical sales from 2020 to 2023, by region

June 19, 2024

Global sales of branded prescription drugs (excluding generics and orphan drugs) are projected to span from 2012 to 2026.

Global sales of branded prescription drugs (excluding generics and orphan drugs) are projected to span from 2012 to 2026.

June 18, 2024

Pharmaceutical R&D Spending: Global Trends from 2014 to 2028

Pharmaceutical R&D Spending: Global Trends from 2014 to 2028

June 16, 2024

Strategic therapeutic Areas mage

Strategic Therapeutic Areas

QuadroPharma has two core business units – Rx (prescription medicine) and consumer health.

pharma exports2

Pharma Exports

At QuadroPharma, We are partnered with more than 300 manufacturers globally.

licensing

Licensing

Seeking exclusive regional rights for ethical pharmaceuticals and consumer health products in high-need areas.